Tradestie Institutional Equity Comparison Engine

MLTX vs IMVT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IMVT Overall Edge

IMVT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immunovant, Inc. Common Stock (IMVT) driven by superior Momentum & Technical, Options & Structure while MLTX counters with relative strength in Growth & Margin. Fundamentally, MLTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus IMVT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against IMVT sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MLTX N/M vs IMVT N/M Fwd P/E
Growth & Margin Winner MLTX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner IMVT
1Y -5.7% vs +46.0% ยท 52W Pos 17% vs 49%
Options & Structure Winner IMVT
BREAKDOWN (7th %ile IV) vs CONSOLIDATION (6th %ile IV)
MLTX NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap $1.1B
1M Return +24.08%
1Y Return -5.65%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 32.0 Fund 44.0 Flow 75.0 Mom 50.0
IMVT NASDAQ
Immunovant, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$33.30
-2.56% 1D
Market Cap $7.3B
1M Return +24.6%
1Y Return +45.95%
Forward P/E N/M
Unified AI Score
39.6 / 100 SELL
Tech 15.0 Fund 36.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MLTX -5.65% IMVT +45.95% Spread: +51.6 pp (IMVT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MLTX TTM Op. Margin: 0.0% IMVT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLTX vs IMVT. Trailing 12-month operating profitability (MLTX 0.0% vs IMVT 0.0%) and valuation multiples (MLTX N/M vs IMVT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MLTX (1) vs IMVT (4)
Institutional Metric MLTX IMVT Criterion Row Winner
Market Capitalization Scale $1.1B $7.3B Larger Scale IMVT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -81.5% -86.5% Higher ROE MLTX
52-Week Range Position Momentum 17% ($9โ€“$23) 49% ($22โ€“$45) Stronger Trend IMVT
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 90% Vol 1.74ฮฒ ยท 72% Vol Lower Realized Risk IMVT
Unified Institutional Score Composite Signal 38.3 / 100 (SELL) 39.6 / 100 (SELL) Higher Composite IMVT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MLTX vs IMVT Buy Guide
MLTX BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MLTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IMVT CONSOLIDATION
93d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live IMVT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MLTX nor IMVT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.